Patent · US Active

Tumor necrosis factor related ligand

US7695934B2 · kind B2 · utility

7Cited by

2References

23Claims

0Family size

Assignees

BIOGEN IDEC MA INC. · US
The Faculty of Medicine of the University of Geneva · CH

Inventors

Jeffrey Browning · Brookline, US
Yves Chicheportiche · Geneva, CH

Key dates

Filing date	Jun 20, 2006
Grant date	Apr 13, 2010
Priority date	—
Expiry date	Jun 20, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2799/026
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Nucleic acids that encode Tumor Necrosis Factor Related Ligand (TRELL), a novel member of the tumor necrosis factor family (TNF), modified TRELL, are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.